Evigrade
DrugsCosmetic ingredientsCalculatorsInteractionsEvigrade SkinEvigrade Meds ↗
ConditionsJournalMethodologyPro for practitioners
ESRU

Pancreatin

AEMPS

Digestives. Multienzyme preparations

ATC code: A09AA02(Multienzymes (lipase, protease etc.))

Brand names: Creon, Pancreaze, Zenpep

Updated · Methodology

Indications

A

Chronic pancreatitis

First line

In chronic pancreatitis with confirmed exocrine insufficiency (fecal elastase < 200 µg/g or clinically evident steatorrhea), pancreatin is a mandatory component of therapy. Without replacement, patients develop weight loss, osteoporosis and fat-soluble vitamin deficiency. The standard starting dose is 25 000–40 000 lipase units per main meal.

Sources

  1. United European Gastroenterol J: United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). (2017)
  2. Минздрав РФ: Хронический панкреатит. Клинические рекомендации (ID 273) (2020)
  3. Gut: Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis. (2017)

ICD-10: K86.1 · ICD-11: DC32

A

Exocrine pancreatic insufficiency

First line

Pancreatic enzyme replacement therapy (PERT) is the standard of care for exocrine pancreatic insufficiency. Evidence is based on RCTs and observational data in chronic pancreatitis, cystic fibrosis and post-pancreatectomy patients. Goals: control steatorrhea, restore nutritional status, normalize absorption of fat-soluble vitamins (A, D, E, K). Dose is titrated by lipase units per kilogram of body weight or per gram of dietary fat.

Sources

  1. Gut: Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis. (2017)
  2. Минздрав РФ: Хронический панкреатит. Клинические рекомендации (ID 273) (2020)
  3. ГРЛС: Панкреатин – Государственный реестр лекарственных средств (2024)
  4. United European Gastroenterol J: United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). (2017)
  5. Gastroenterology: AGA Clinical Practice Update on the Epidemiology, Evaluation, and Management of Exocrine Pancreatic Insufficiency: Expert Review. (2023)

ICD-10: K86.8 · ICD-11: DC35.1

A

Pancreatic insufficiency in cystic fibrosis

First line

85% of cystic fibrosis patients develop exocrine insufficiency from childhood. PERT is lifelong, started immediately after diagnosis. Doses are based on lipase per kilogram of body weight: 500–1000 IU lipase/kg/meal in children, 500–2500 IU lipase/kg/meal in adults. Maximum 10 000 IU lipase/kg/day to prevent fibrosing colonopathy.

Sources

  1. Clinical Nutrition: ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis (2016)
  2. ГРЛС: Панкреатин – Государственный реестр лекарственных средств (2024)
  3. Cochrane Database Syst Rev: Pancreatic enzyme replacement therapy for people with cystic fibrosis. (2020)
  4. J Pediatr: Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. Consensus Committee. (1995)

ICD-10: E84.8 · ICD-11: CA25.0

A

Post-pancreatectomy state

First line

After partial or total pancreatic resection, PERT is initiated as soon as oral nutrition resumes and continued lifelong after total pancreatectomy. The dose depends on resection extent and is titrated clinically: weight, stool frequency and character, symptoms.

Sources

  1. Минздрав РФ: Хронический панкреатит. Клинические рекомендации (ID 273) (2020)
  2. Surgery: Nutritional support and therapy in pancreatic surgery: A position paper of the International Study Group on Pancreatic Surgery (ISGPS). (2018)
  3. BMC Surg: Pancreatic exocrine insufficiency after pancreatic resection: a systematic review. (2025)

ICD-10: K91.8 · ICD-11: DE13

Marketing claims without evidence base

The drug is promoted for these uses outside international guidelines. Each entry below is analyzed against AEMPS, FDA, EMA, Cochrane and major RCTs.

D

Postprandial discomfort

Not recommended

Pancreatin is an enzyme preparation that doctors prescribe for pancreatic insufficiency, and it is also marketed as a remedy for heaviness and discomfort after ordinary meals. For this kind of discomfort, without confirmed enzyme deficiency, pancreatin has not shown convincing benefit – there is no evidence base for this use. If meals regularly bring heaviness, bloating or pain, it is worth discussing the cause with a doctor: reviewing diet and eating habits helps, and enzymes are taken when a genuine deficiency is found.

Sources

  1. Минздрав РФ: Хронический панкреатит. Клинические рекомендации (ID 273) (2020)

ICD-10: K30 · ICD-11: DD90.3

How to read tiers A–F
  • AStrong evidence – first or second line in international guidelines
  • BRecommended in selected cases
  • CStudy data contradict each other
  • DBenefit not proven, no documented harm
  • FDocumented harm, or risk without benefit

Mechanism of action

Contains proteolytic, amylolytic and lipolytic enzymes of animal origin (porcine pancreas). Replaces the exocrine pancreatic function when it is deficient. The enteric coating of microspheres protects enzymes from inactivation by gastric acid; activation occurs in the small intestine at pH > 5.5. Efficacy depends on lipase content – the key enzyme for steatorrhea.

Safety

Contraindications

  • Acute pancreatitis
  • Acute phase of chronic pancreatitis exacerbation
  • Hypersensitivity to porcine protein
  • Bowel obstruction

Serious adverse effects

  • Fibrosing colonopathy in pediatric CF patients at doses above 10 000 IU lipase/kg/day
  • Anaphylactic reactions (rare)

Common adverse effects

  • Diarrhea, constipation, abdominal discomfort
  • Nausea
  • Rash, pruritus

Uncommon adverse effects

  • Perianal irritation in children
  • Hyperuricemia and urinary uric acid crystals at high doses

Pregnancy: can you take Pancreatin?

AEMPS summary of product characteristics (section 4.6): there are no or limited data (fewer than 300 pregnancy outcomes) on the use of porcine pancreatic enzymes in pregnant women. There are no animal data on reproductive toxicity, but animal studies show no evidence that the enzymes are absorbed, so no reproductive or developmental toxicity is expected. Pancreatin can be used in pregnancy if needed to provide adequate nutritional support to a pregnant woman with exocrine pancreatic insufficiency.

Breastfeeding: can you take Pancreatin?

Enzymes are not absorbed and do not transfer into milk in active form. Use during breastfeeding is acceptable.

Calculate RID

Reference information, not a clinical decision. Discuss feeding pauses or changes with your physician or an IBCLC.

Practical notes

Timing and administration

Taken with meals: 1/3 of the dose at the start, 2/3 during the meal. Capsules are swallowed whole. If swallowing is not possible (children, dysphagia), capsule contents are mixed with a small volume of non-hot acidic liquid (fruit puree, lemon water) and taken immediately without chewing the microspheres. Alkaline liquids (milk, mineral water) destroy the enteric coating.

Dose titration

Starting dose in adults: 25 000–40 000 IU lipase per main meal, 10 000–25 000 IU per snack. The dose is increased for persistent steatorrhea and weight loss, with clinical reassessment in 2–4 weeks. Do not exceed 10 000 IU lipase/kg/day – risk of fibrosing colonopathy in pediatric CF patients. Adding a PPI improves efficacy in some patients by ensuring an alkaline duodenum for enzyme activation.

Monitoring

Efficacy is judged by weight change, stool frequency and character, fecal elastase, fat-soluble vitamin levels (A, D, E), albumin and prealbumin. In CF and chronic pancreatitis patients, bone mineral density is checked every 2 years.

Special situations

In concurrent diabetes due to chronic pancreatitis, pancreatin is not discontinued – digestive enzymes do not affect carbohydrate metabolism. In patients with pork allergy, prescribe with caution (porcine pancreatic antigen). In the acute phase of pancreatitis, pancreatin is not used.

Common myths

Myth: «Creon is helpful after a festive meal». Fact: a healthy pancreas handles any meal load. Prophylactic enzyme use «just in case» is not indicated and may mask diagnostically important symptoms.

Myth: «pancreatin helps any epigastric heaviness». Fact: heaviness more often reflects GERD, functional dyspepsia, H. pylori gastritis, biliary disease. Enzymes do not target these mechanisms.

Myth: «children take enzymes to improve appetite». Fact: pancreatin is prescribed only for confirmed pancreatic insufficiency, not «for growth and appetite».

Check interaction with another drug

Opens the checker prefilled with this drug. Pick the second one from your regimen.

Open checker

Summary of a multi-drug list →

Medicine list: everything you take in one place →

Frequently asked

What is Pancreatin used for?

Pancreatin is evaluated for the following indications with varying evidence strength: Pancreatic insufficiency in cystic fibrosis (evidence tier A), Post-pancreatectomy state (evidence tier A), Chronic pancreatitis (evidence tier A). See the full indication matrix with dosing and citations above on this page.

What are the side effects of Pancreatin?

Common side effects of Pancreatin (≥ 1 in 100): Diarrhea, constipation, abdominal discomfort, Nausea, Rash, pruritus. See the Safety section for uncommon and serious reactions.

Is Pancreatin safe during pregnancy?

AEMPS summary of product characteristics (section 4.6): there are no or limited data (fewer than 300 pregnancy outcomes) on the use of porcine pancreatic enzymes in pregnant women. There are no animal data on reproductive toxicity, but animal studies show no evidence that the enzymes are absorbed, so no reproductive or developmental toxicity is expected. Pancreatin can be used in pregnancy if needed to provide adequate nutritional support to a pregnant woman with exocrine pancreatic insufficiency.

Is Pancreatin compatible with breastfeeding?

Enzymes are not absorbed and do not transfer into milk in active form. Use during breastfeeding is acceptable.

Who should not take Pancreatin?

Pancreatin is contraindicated in: Acute pancreatitis; Acute phase of chronic pancreatitis exacerbation; Hypersensitivity to porcine protein; Bowel obstruction. Full list in the Safety section.

Creon is helpful after a festive meal

a healthy pancreas handles any meal load. Prophylactic enzyme use «just in case» is not indicated and may mask diagnostically important symptoms.

pancreatin helps any epigastric heaviness

heaviness more often reflects GERD, functional dyspepsia, H. pylori gastritis, biliary disease. Enzymes do not target these mechanisms.

children take enzymes to improve appetite

pancreatin is prescribed only for confirmed pancreatic insufficiency, not «for growth and appetite».

Official sources

Direct links to regulator labels. Open in a new tab.

Other drugs in this group

Betaine hydrochloride, Bromelain (pineapple enzyme)